It’s been five years in the making, yet a bill requiring online retailers to label the country of origin for merchandise remains a tough sell in Congress—even among the lawmakers who introduced it back in 2020.
It’s been a rough start to 2025 for Indian pharmaceutical giants. Four of India’s biggest generic drug producers issued product recalls in the last three months.
